Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 185.97

-0.4%

Feb 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Abuckatatime who wrote (7656)	9/25/1997 4:23:00 PM
From: Henry Niman	of 32384

Greg, In that past, AGN's focus has been skin and eye diseases. However, I thought that the split up of the retinoid/rexinoids would allow them to expand their horizons through alliances. They did talk about corporate partner opportunities which I assumed would be along the same lines as LGND's alliances. They were initailly focusing on their specialty (skin diseases), but they included oncology and "other indications" when they discussed their research focus. AGN has been looking for an acquirer for some time. It may still be JNJ who has plenty of muscle and may very well target many areas simultaneously.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next